Sincrolab

About:

Sincrolab offers an Artificial Intelligence digital prescription neuro medicine based on videogames delivered through mobile devices.

Website: http://www.sincrolab.es/

Twitter/X: sincrolab_es

Top Investors: Wayra, Eoniq.fund, Clave, Growth Venture Partners

Description:

Sincrolab is a company dedicated to the design and commercialization of technological tools for neuropsychological rehabilitation of patients with neurodevelopmental disorders. It offers an Artificial Intelligence digital prescription neuro medicine based on videogames delivered through mobile devices.

Total Funding Amount:

1.8M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Madrid, Madrid, Spain

Founded Date:

2013-01-01

Contact Email:

info(AT)sincrolab.es

Founders:

Daniel Garrido, Ignacio de Ramón Burgos, María Laorden Baeza

Number of Employees:

11-50

Last Funding Date:

2024-06-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai